Government News

Join WhatsApp Channel 

Crack GPAT — Prepare for GPAT Online
  • DCC refers retail pharmacy deregulation proposals to sub-committee, including removal of pharmacist name from licence
    2 April 2026

    DCC refers retail pharmacy deregulation proposals to sub-committee, including removal of pharmacist name from licence

    In a significant step toward easing the regulatory burden on India's retail pharmacy sector, the Drugs Consultative Committee (DCC) at its 68th meeting on 20 March 2026 directed a sub-committee to examine four landmark deregulation proposals. The sub-committee's findings will be placed before the DCC for final deliberation before any rule amendments are made.

  • 23 March 2026
    DTAB Backs Major Reform : All Antimicrobials May Soon Be Classified as “New Drugs” in India

    In a significant development for India’s pharmaceutical regulatory landscape, the Drugs Technical Advisory Board (DTAB) has reaffirmed its position to include all antimicrobial drugs under the definition of “New Drugs” as per the New Drugs and Clinical Trials Rules, 2019.

    The decision was taken during the 93rd meeting of DTAB held on February 16, 2026, at FDA Bhawan, New Delhi, conducted in a hybrid format. The board reviewed and approved the Action Taken Report (ATR) from its previous (92nd) meeting held on April 24, 2025.

  • 5 March 2026
    CDSCO Issues Alert After Theft of Sanofi Lantus Insulin Pens During Transit

    India’s drug regulator has issued a public advisory after a consignment of insulin pens manufactured by Sanofi India Limited was reported stolen during transportation, raising concerns about potential risks if the products enter the market through unauthorized channels.

  • 5 March 2026
    CDSCO Announces Faster NOC Process for Drug Testing Before Approval
    The regulator has announced that companies will now receive the No Objection Certificate, NOC more quickly, helping to streamline regulatory procedures and reduce approval timelines.
  • 26 February 2026
    India and Brazil Sign MoU to Boost Pharmaceutical Regulatory Cooperation
    India and Brazil formalised a partnership to deepen cooperation in the regulation of pharmaceutical and medical products by signing a Memorandum of Understanding (MoU) between India’s Central Drugs Standard Control Organisation (CDSCO) and the Brazilian Health Regulatory Agency (ANVISA).
  • 26 February 2026
    India Transitions to Td Vaccine Under National Immunization Programme
    In a major step to strengthen the country’s immunization framework, Union Health Minister JP Nadda inaugurated the indigenously manufactured Tetanus and Adult Diphtheria (Td) vaccine at the Central Research Institute (CRI), Kasauli
  • 12 February 2026
    CDSCO Approves AstraZeneca’s Imfinzi for Advanced Endometrial Cancer in India
    AstraZeneca Pharma India Limited has received permission from the Central Drugs Standard Control Organisation (CDSCO), Directorate General of Health Services, Government of India, to import and market Durvalumab Solution for Infusion 120 mg/2.4 mL and 500 mg/10 mL, sold under the brand name Imfinzi, for an additional indication in India.
  • 9 February 2026
    Path Opens for CGHS Pharmacists to Become Gazetted Officers
    In a major and long-awaited development, the Central Government has notified the Recruitment Rules for the posts of Depot Manager (DM) and Assistant Depot Manager (ADM) under the Central Government Health Scheme (CGHS).
  • 3 February 2026
    IPC Urges Medical Device Companies to Strengthen Adverse Event Reporting Under MvPI
    The Indian Pharmacopoeia Commission (IPC), under the Ministry of Health and Family Welfare, has urged all Medical Device Marketing Authorisation Holders (MAHs) to ensure strict compliance with adverse event reporting under the Materiovigilance Programme of India (MvPI), stressing that timely reporting is critical to patient safety and effective regulatory oversight.
  • 2 February 2026
    Budget Boost to Make India a Global Biopharma Hub
    In a major push for India’s pharmaceutical and biopharmaceutical sectors, the Union Budget 2026-27, presented by Finance Minister Smt. Nirmala Sitharaman in Parliament today, announced comprehensive initiatives aimed at strengthening domestic capacity, fostering innovation and positioning India as a global biomanufacturing leader.
Subscribe to Government News